Kyle C. Molina, PharmD, BCIDP, AAHIVP

Infectious Disease Clinical Pharmacy Specialist
University of Colorado Hospital

Disclosure(s): No financial relationships to disclose

Poster(s):

• 356 - Risk Assessment of Pneumocystis jirovecii Pneumonia among Hospitalized Patients with Hypoxic Respiratory Failure - A Proposed Multivariable Calculator Based on Previous Prednisone Equivalent Dose
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 472 - Corticosteroid Exposure as a Risk Factor for Pneumocystis jirovecii Pneumonia Mortality in HIV-Negative Patients: A Multicenter Retrospective Case-Control Study with a Global Research Network Validation
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 633 - Eravacycline Use in Immunocompromised Patients: Multicenter Evaluation of Clinical and Safety Endpoints
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1422 - A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1986 - Multicenter evaluation of Staphylococcus aureus prosthetic valve infective endocarditis with and without gentamicin treatment: Is it time to revisit?
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET